Ms. Nancy A. Mismash

Nancy A. Mismash joined Robert DeBry in November 1997after working as in house counsel for a nutraceutical company where she was in charge of FDA compliance, patent and trademark procurement, and outside litigation.

As the lead attorney for Mass Torts at Robert DeBry & Associates, Nancy has dedicated her career to helping people that have been injured by dangerous drugs and unsafe medical devices. Her practice includes complex civil litigation, pharmaceutical and general products liability, multi-district litigation, consumer protection, personal injury, wrongful death, and class action litigation. She has successfully represented clients in claims against pharmaceutical giants such as Bayer, Johnson & Johnson, GlaxoSmithKline and Pfizer as well as medical device manufactures Bard, Boston Scientific, Medtronic, and Zimmer.

Nancy has great compassion and sympathy for each new client she represents. She is a longstanding member of the American Association of Justice (AAJ), a nonprofit organization that is dedicated to maintaining a fair and equal justice system. As an active member of the AAJ, she has participated in the Ortho Evra Litigation Group, the VIOXX Litigation Group, and the VIOXX Discovery Committee.

Nancy is actively representing clients injured by Actos, Avandia, Fosamax, Granuflo, Januvia, Nuvaring, Testosterone replacement therapies, Xarelto, Yasmine, Yaz, and Zofran.

Nancy earned her bachelor’s degree from the University of Utah in 1988 in Political Science and Economics. She completed post-graduate work in Economics before attending law school. She graduated from the University of Idaho, College of Law in 1992 and was admitted to the Utah State Bar that same year.

Nancy is an avid equestrian. She is a member of the American Quarter Horse Association and serves as a board member for the Utah Quarter Horse Association. When not working, she enjoys trail riding with her daughter and friends or attending horse shows. During the winter months she enjoys watching her son compete in men’s gymnastics.